| scholarly article | Q13442814 |
| P50 | author | Steven Silverstein | Q99565091 |
| Michel Guillon | Q99565092 | ||
| Marc-Matthias Schulze | Q99565093 | ||
| David Galarreta | Q99565094 | ||
| P2093 | author name string | Sruthi Srinivasan | |
| Elizabeth Yeu | |||
| Venkiteshwar Manoj | |||
| P2860 | cites work | Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium | Q93389679 |
| A two-week clinical evaluation of the safety of Systane Ultra in contact lens-wearing patients | Q33644152 | ||
| Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye | Q34610545 | ||
| Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests | Q35542950 | ||
| Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution | Q35799409 | ||
| Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb | Q35854966 | ||
| Impact of dry eye disease and treatment on quality of life | Q37751734 | ||
| TFOS DEWS II Diagnostic Methodology report | Q38652978 | ||
| TFOS DEWS II Tear Film Report. | Q38652990 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population | Q39368767 | ||
| TFOS DEWS II Management and Therapy Report | Q39453364 | ||
| Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops | Q42601854 | ||
| Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation | Q42960968 | ||
| A clinical evaluation of Systane | Q46940898 | ||
| Tear instability importance, mechanisms, validity and reliability of assessment. | Q50034015 | ||
| Management of dry eye in UK pharmacies. | Q51069083 | ||
| Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study | Q60307243 | ||
| Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial | Q61054786 | ||
| The effects of anionic and zwitterionic phospholipids on the tear film lipid layer | Q73071842 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 2561-2570 | |
| P577 | publication date | 2020-09-01 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial | |
| P478 | volume | 14 |
Search more.